Home  >  Products  >  Kcnh2 (potassium voltage-gated channel, subfamily H (eag-related), member 2 ) Blocking Peptide (the C terminal of Kcnh2)(100ug)
Kcnh2 (potassium voltage-gated channel, subfamily H (eag-related), member 2 ) Blocking Peptide (the C terminal of Kcnh2)(100ug)

Kcnh2 (potassium voltage-gated channel, subfamily H (eag-related), member 2 ) Blocking Peptide (the C terminal of Kcnh2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Kcnh2 Antibody (ARP34928_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Mouse
Presku: AAP34928
Size: 100ug
Weight: 127kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Kcnh2 is a pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel. Channel properties are modulated by cAMP and subunit assembly. It mediates the rapidly activating component of the delayed rectifying potassium current in heart (IKr).
Alternative names: AI326795; ERG1; LQT; Lqt2; M-erg; Merg1; merg1a; merg1b
See Full Product Listings >